Kelly, S.J.; Hirani, A.; Shahidadpury, V.; Solanki, A.; Halasz, K.; Varghese Gupta, S.; Madow, B.; Sutariya, V.
Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report. Biomedicines 2018, 6, 92.
https://doi.org/10.3390/biomedicines6030092
AMA Style
Kelly SJ, Hirani A, Shahidadpury V, Solanki A, Halasz K, Varghese Gupta S, Madow B, Sutariya V.
Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report. Biomedicines. 2018; 6(3):92.
https://doi.org/10.3390/biomedicines6030092
Chicago/Turabian Style
Kelly, Shannon J., Anjali Hirani, Vishal Shahidadpury, Aum Solanki, Kathleen Halasz, Sheeba Varghese Gupta, Brian Madow, and Vijaykumar Sutariya.
2018. "Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report" Biomedicines 6, no. 3: 92.
https://doi.org/10.3390/biomedicines6030092
APA Style
Kelly, S. J., Hirani, A., Shahidadpury, V., Solanki, A., Halasz, K., Varghese Gupta, S., Madow, B., & Sutariya, V.
(2018). Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report. Biomedicines, 6(3), 92.
https://doi.org/10.3390/biomedicines6030092